Bacteria can cause a range of infections, and sometimes the best way to fight off these stubborn “bugs” is by using antibiotics. However, many strains of bacteria can
In recent years deaths from opioid overdoses have become one of the most common injury-related deaths in North America. The continent also has the highest per capita rate
CALGARY, Alberta and SAN DIEGO, Oct. 22, 2018 (GLOBE NEWSWIRE) — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus turning cold
MALVERN, Penn. — October 15, 2018 — Galera Therapeutics, Inc., a clinical-stage biotechnology company focused on the development of drugs targeting oxygen metabolic pathways with the potential to
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer, according to a new study published in the journal Radiology. The researchers said
Geneva, Switzerland and Boston, MA – October 9, 2018 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization
Copenhagen, September 28, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced encouraging top-line results for its clinical
TUESDAY, Sept. 25, 2018 — A major non-profit advocacy group is asking that a large government trial comparing treatments for sepsis be shut down. The trial, called Clovers,
Highmark Health operates a program it calls Highmark VITAL, which helps make FDA-approved, leading-edge technologies available sooner for patients by partnering with physicians and industry players and helping
Another clue about Amazon’s intentions for healthcare emerged on Thursday when reports broke that the online retailer is planning to build primary care clinics for Seattle employees. The
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
